The Oklahoma Medical Marijuana Authority (OMMA) commissioned Cannabis Public Policy Consulting (CPPC) to conduct a study designed to provide a comprehensive and multi-faceted examination of supply chain and demand outputs of the medical cannabis market in Oklahoma.

It is the first state-commissioned cannabis supply and demand study to CPPC's knowledge to conjoin time-matched, substate measures of cannabis supply and market-specific demand in a single study, thus facilitating one of the most comprehensive cannabis market investigations in the world.

Download the Supply and Demand Study.

Dear stakeholders, partners, and fellow Oklahomans,

I want to present you with OMMA’s strategic response to address the findings of a groundbreaking report that quantifies and confirms what has long been suspected: Oklahoma is facing a significant oversupply of regulated medical marijuana.

First and foremost, OMMA is steadfast in our commitment to serving the needs of Oklahoma medical marijuana patients. It is essential that we address this oversupply head-on, not only to ensure the integrity and sustainability of our medical marijuana market for our patients, but to promote public safety and mitigate the dangers that coincide with illicit marijuana activity for all Oklahomans.

Our strategic response employs a multi-pronged approach to address the litany of issues that perpetuate and exacerbate the oversupply of marijuana in our medical system and to respond to the illicit activity that threatens Oklahomans’ health and safety. Through strategic partnerships, rigorous oversight, streamlined compliance monitoring, advancements of smart policies, and stakeholder engagement, we can foster an environment that promotes safety and prevents large-scale diversion.

At OMMA, we understand the importance of transparency and will be providing updates on our progress. We have implemented key performance indicators (KPIs) to measure the success of our response efforts, and through reporting and regular communication, we aim to keep all stakeholders informed of our efforts.

Together, we will address the oversupply of marijuana, safeguard the integrity of our medical market, and ensure the safety of our patients. OMMA stands ready to face these challenges head-on, equipped with new data, targeted insights, and the determination to build a thriving medical marijuana program for the benefit of Oklahoma.

Sincerely,
Adria Berry
Executive Director
Oklahoma's Medical Marijuana Authority (OMMA)

Download the OMMA Strategic Response.